Linkage studies were performed in six European families with hyperkalaemic periodic paralysis (PPII) with myotonia, an autosomal dominantly inherited disorder characterised by episodic weakness. The weakness is caused by non-inactivating sodium channels of reduced single channel conductance of the muscle fibre membrane. Recently, portions of the gene coding for the a subunit of the sodium Zentrum fur Humangenetik, Abteilung Allgemeine
channel of the adult human skeletal muscle (h-Na2) have been cloned and localised on chromosome 17q with no recombinants to the human growth hormone locus (GH1). Linkage between these two chromosome 17 markers and the disease was shown in our families (Z=7-14, 0=0 00). These results, combined with the linkage data of a single large American family, suggest that the disease is caused by dominant mutations of the adult sodium channel, and that it is probably a genetically homogeneous disorder. Hyperkalaemic periodic paralysis is the first non-progressive myotonic disorder to be localised on the human genome.
The non-progressive myotonic disorders are a clinically and genetically heterogeneous group of muscle diseases having in common the variable symptom of myotonia (table 1) . In vitro studies of the electrical membrane properties of muscle fibres in affected patients with these diseases have shown that the pathophysiological defects could be caused by disturbances in the voltage dependent gating of different ion channels.
Periodic paralysis with hyperkalaemia during attacks was first conclusively described by Gamstorp3 in 1956. She named the disorder adynamia episodica herditaria. Inheritance is autosomal dominant with high penetrance in both sexes. Three clinically different subtypes of hyperkalaemic periodic paralysis (PPII, MIM 170500) exist: (1) without myotonia, (2) with electromyographic and clinical myotonia, or (3) with paramyotonia. The prevalence of myotonic PPII is low and no reliable estimates exist for the Caucasian population. In vitro studies of muscle fibres in patients with myotonic PPII have shown that in the state of weakness the muscle fibres are depolarised to an extent that the membrane is inexcitable. A pathological inward sodium current, which can be completely blocked by tetrodotoxin, is the cause of the depolarisation.6 This sodium current was found to be conducted by non-inactivating sodium channels, which enter a pathological state of reduced single channel conductance. 7 Recently the a subunit of the adult human skeletal muscle sodium channel, h-Na2, was cloned and localised to the long arm of chromosome 17.8 In addition, this cDNA probe was shown to be linked with no recombinants to the human growth hormone gene, GH1, on 17q22-24. Analysis of linkage of an extended American family with myotonic PPII showed a combined lod score of Z = 7-02 at 0 = 0 00 with the cDNA probes h-Na2 and GHl.P From these results the authors drew the conclusion that the a subunit of the adult human skeletal muscle sodium channel might be the site of the primary defect in myotonic PPII 
Results
The lod scores at recombination fractions from 0 00 to 0-4 for PPII versus the h-Na2 and hGH polymorphisms (separately and their combined haplotypes) are shown in table 3. There were 23 scorable meioses; the disease was transmitted 13 times through the female line and five times through the male line. All key family members were typed with the h-Na2 and hGH gene probes. The informative polymorphism with either probe was used to type the remaining family members. There was no recombination between the markers and PPII; one family was only partly informative. The haplotype of the two probes is closely linked to PPII with a maximum lod score of 7-14 at 0=0-00 (support interval 0-00 to 0 07). The support intervals for the h-Na2 data and hGH data alone were 0 00 to 0-15 and 0 00 to 0 09, respectively. The British family on its own showed a multipoint lod score of 2-76 at 0 = 0 00 with no recombinants. With the localisation of myotonic PPII, the important question about heterogeneity of the autosomal dominant, non-progressive myotonic disorders with episodic paralysis might be answered, a subject of long standing discussion"1617 for the following reasons. Myotonic PPII patients with hyperkalaemic periodic paralysis in combination with paramyotonia2 (paralysis periodica paramyotonica) suffer from hyperkalaemic attacks, but have in addition cold induced stiffness followed by flaccid weakness, which is a hallmark of paramyotonia congenita. In normokalaemic periodic paralysis attacks resemble PPII, but without significant increase of serum potassium during the attack."
All these disorders are thought to be associated with altered functions of the muscle sodium channels. Only molecular studies in well defined families will provide further evidence of whether these disorders are variants of the same genetic condition or genetically different diseases. The slightly different clinical symptoms in myotonic disorders with episodic weakness might be the result of malfunctions in the same muscle sodium channel. Channel disturbances could be caused by an allelic series of mutations at the same gene locus, by post-transcriptional or post-translational modifications of the gene product.
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